InvestorsHub Logo
Followers 43
Posts 2488
Boards Moderated 0
Alias Born 10/19/2015

Re: dadofmarcmax post# 183228

Wednesday, 02/27/2019 3:33:35 PM

Wednesday, February 27, 2019 3:33:35 PM

Post# of 463666
It's not at the expense of one over the other.

It's that every indication that Anavex wants to treat, that there is a current drug that works well, is going to put a ceiling on the overall value of this stock.

If tomorrow a Parkinson's drug comes out that cures the disease, that would be a bad thing for Anavaex, right?

Same principle applies here. Epilepsy was one of the indications Anavex hoped to treat. The fact that GW Pharma has come out with something that seems to work well is wonderful news for your patients, but it diminishes the overall value of Anavex's drug compound if there's less incentive to prescribe it instead of Epidolex.

I hope you're right that Epidolex doesn't come at Anavex's expense. I would prefer (selfishly) for there to be nothing that works well so that Anavex is the only game in town when it comes to treating neurological disorders.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News